Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychiatric Medications Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Antidepressants
1.2.3 Anti-anxiety Medications
1.2.4 Mood-stabilizing Medications
1.2.5 Antipsychotic Medications
1.3 Market by Application
1.3.1 Global Psychiatric Medications Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psychiatric Medications Market Perspective (2018-2034)
2.2 Psychiatric Medications Growth Trends by Region
2.2.1 Global Psychiatric Medications Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Psychiatric Medications Historic Market Size by Region (2018-2023)
2.2.3 Psychiatric Medications Forecasted Market Size by Region (2024-2034)
2.3 Psychiatric Medications Market Dynamics
2.3.1 Psychiatric Medications Industry Trends
2.3.2 Psychiatric Medications Market Drivers
2.3.3 Psychiatric Medications Market Challenges
2.3.4 Psychiatric Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychiatric Medications Players by Revenue
3.1.1 Global Top Psychiatric Medications Players by Revenue (2018-2023)
3.1.2 Global Psychiatric Medications Revenue Market Share by Players (2018-2023)
3.2 Global Psychiatric Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psychiatric Medications Revenue
3.4 Global Psychiatric Medications Market Concentration Ratio
3.4.1 Global Psychiatric Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychiatric Medications Revenue in 2024
3.5 Psychiatric Medications Key Players Head office and Area Served
3.6 Key Players Psychiatric Medications Product Solution and Service
3.7 Date of Enter into Psychiatric Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychiatric Medications Breakdown Data by Type
4.1 Global Psychiatric Medications Historic Market Size by Type (2018-2023)
4.2 Global Psychiatric Medications Forecasted Market Size by Type (2024-2034)
5 Psychiatric Medications Breakdown Data by Application
5.1 Global Psychiatric Medications Historic Market Size by Application (2018-2023)
5.2 Global Psychiatric Medications Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Psychiatric Medications Market Size (2018-2034)
6.2 North America Psychiatric Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Psychiatric Medications Market Size by Country (2018-2023)
6.4 North America Psychiatric Medications Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psychiatric Medications Market Size (2018-2034)
7.2 Europe Psychiatric Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Psychiatric Medications Market Size by Country (2018-2023)
7.4 Europe Psychiatric Medications Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psychiatric Medications Market Size (2018-2034)
8.2 Asia-Pacific Psychiatric Medications Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Psychiatric Medications Market Size by Region (2018-2023)
8.4 Asia-Pacific Psychiatric Medications Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psychiatric Medications Market Size (2018-2034)
9.2 Latin America Psychiatric Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Psychiatric Medications Market Size by Country (2018-2023)
9.4 Latin America Psychiatric Medications Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychiatric Medications Market Size (2018-2034)
10.2 Middle East & Africa Psychiatric Medications Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Psychiatric Medications Market Size by Country (2018-2023)
10.4 Middle East & Africa Psychiatric Medications Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psychiatric Medications Introduction
11.1.4 Pfizer Revenue in Psychiatric Medications Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Psychiatric Medications Introduction
11.2.4 AstraZeneca Revenue in Psychiatric Medications Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Detail
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Psychiatric Medications Introduction
11.3.4 Eli Lilly and Company Revenue in Psychiatric Medications Business (2018-2023)
11.3.5 Eli Lilly and Company Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Psychiatric Medications Introduction
11.4.4 GlaxoSmithKline Revenue in Psychiatric Medications Business (2018-2023)
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Psychiatric Medications Introduction
11.5.4 Johnson & Johnson Revenue in Psychiatric Medications Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Psychiatric Medications Introduction
11.6.4 Novartis Revenue in Psychiatric Medications Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 H. Lundbeck
11.7.1 H. Lundbeck Company Detail
11.7.2 H. Lundbeck Business Overview
11.7.3 H. Lundbeck Psychiatric Medications Introduction
11.7.4 H. Lundbeck Revenue in Psychiatric Medications Business (2018-2023)
11.7.5 H. Lundbeck Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Psychiatric Medications Introduction
11.8.4 Abbott Laboratories Revenue in Psychiatric Medications Business (2018-2023)
11.8.5 Abbott Laboratories Recent Development
11.9 Otsuka Pharmaceutical
11.9.1 Otsuka Pharmaceutical Company Detail
11.9.2 Otsuka Pharmaceutical Business Overview
11.9.3 Otsuka Pharmaceutical Psychiatric Medications Introduction
11.9.4 Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2018-2023)
11.9.5 Otsuka Pharmaceutical Recent Development
11.10 Gedeon Richter
11.10.1 Gedeon Richter Company Detail
11.10.2 Gedeon Richter Business Overview
11.10.3 Gedeon Richter Psychiatric Medications Introduction
11.10.4 Gedeon Richter Revenue in Psychiatric Medications Business (2018-2023)
11.10.5 Gedeon Richter Recent Development
11.11 Lupin Pharmaceuticals
11.11.1 Lupin Pharmaceuticals Company Detail
11.11.2 Lupin Pharmaceuticals Business Overview
11.11.3 Lupin Pharmaceuticals Psychiatric Medications Introduction
11.11.4 Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2018-2023)
11.11.5 Lupin Pharmaceuticals Recent Development
11.12 Luye Pharma
11.12.1 Luye Pharma Company Detail
11.12.2 Luye Pharma Business Overview
11.12.3 Luye Pharma Psychiatric Medications Introduction
11.12.4 Luye Pharma Revenue in Psychiatric Medications Business (2018-2023)
11.12.5 Luye Pharma Recent Development
11.13 SK Biopharmaceuticals
11.13.1 SK Biopharmaceuticals Company Detail
11.13.2 SK Biopharmaceuticals Business Overview
11.13.3 SK Biopharmaceuticals Psychiatric Medications Introduction
11.13.4 SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2018-2023)
11.13.5 SK Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Psychiatric Medications Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Antidepressants
Table 3. Key Players of Anti-anxiety Medications
Table 4. Key Players of Mood-stabilizing Medications
Table 5. Key Players of Antipsychotic Medications
Table 6. Global Psychiatric Medications Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Psychiatric Medications Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Psychiatric Medications Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Psychiatric Medications Market Share by Region (2018-2023)
Table 10. Global Psychiatric Medications Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Psychiatric Medications Market Share by Region (2024-2034)
Table 12. Psychiatric Medications Market Trends
Table 13. Psychiatric Medications Market Drivers
Table 14. Psychiatric Medications Market Challenges
Table 15. Psychiatric Medications Market Restraints
Table 16. Global Psychiatric Medications Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Psychiatric Medications Market Share by Players (2018-2023)
Table 18. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Medications as of 2024)
Table 19. Ranking of Global Top Psychiatric Medications Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Psychiatric Medications Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psychiatric Medications Product Solution and Service
Table 23. Date of Enter into Psychiatric Medications Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psychiatric Medications Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Psychiatric Medications Revenue Market Share by Type (2018-2023)
Table 27. Global Psychiatric Medications Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Psychiatric Medications Revenue Market Share by Type (2024-2034)
Table 29. Global Psychiatric Medications Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Psychiatric Medications Revenue Market Share by Application (2018-2023)
Table 31. Global Psychiatric Medications Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Psychiatric Medications Revenue Market Share by Application (2024-2034)
Table 33. North America Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Psychiatric Medications Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Psychiatric Medications Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Psychiatric Medications Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Psychiatric Medications Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Psychiatric Medications Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Psychiatric Medications Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Psychiatric Medications Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Psychiatric Medications Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Psychiatric Medications Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Psychiatric Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Psychiatric Medications Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Psychiatric Medications Market Size by Country (2024-2034) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Psychiatric Medications Product
Table 51. Pfizer Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Psychiatric Medications Product
Table 56. AstraZeneca Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Eli Lilly and Company Company Detail
Table 59. Eli Lilly and Company Business Overview
Table 60. Eli Lilly and Company Psychiatric Medications Product
Table 61. Eli Lilly and Company Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 62. Eli Lilly and Company Recent Development
Table 63. GlaxoSmithKline Company Detail
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Psychiatric Medications Product
Table 66. GlaxoSmithKline Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. Johnson & Johnson Company Detail
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Psychiatric Medications Product
Table 71. Johnson & Johnson Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Development
Table 73. Novartis Company Detail
Table 74. Novartis Business Overview
Table 75. Novartis Psychiatric Medications Product
Table 76. Novartis Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. H. Lundbeck Company Detail
Table 79. H. Lundbeck Business Overview
Table 80. H. Lundbeck Psychiatric Medications Product
Table 81. H. Lundbeck Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 82. H. Lundbeck Recent Development
Table 83. Abbott Laboratories Company Detail
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Psychiatric Medications Product
Table 86. Abbott Laboratories Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 87. Abbott Laboratories Recent Development
Table 88. Otsuka Pharmaceutical Company Detail
Table 89. Otsuka Pharmaceutical Business Overview
Table 90. Otsuka Pharmaceutical Psychiatric Medications Product
Table 91. Otsuka Pharmaceutical Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 92. Otsuka Pharmaceutical Recent Development
Table 93. Gedeon Richter Company Detail
Table 94. Gedeon Richter Business Overview
Table 95. Gedeon Richter Psychiatric Medications Product
Table 96. Gedeon Richter Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 97. Gedeon Richter Recent Development
Table 98. Lupin Pharmaceuticals Company Detail
Table 99. Lupin Pharmaceuticals Business Overview
Table 100. Lupin Pharmaceuticals Psychiatric Medications Product
Table 101. Lupin Pharmaceuticals Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 102. Lupin Pharmaceuticals Recent Development
Table 103. Luye Pharma Company Detail
Table 104. Luye Pharma Business Overview
Table 105. Luye Pharma Psychiatric Medications Product
Table 106. Luye Pharma Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 107. Luye Pharma Recent Development
Table 108. SK Biopharmaceuticals Company Detail
Table 109. SK Biopharmaceuticals Business Overview
Table 110. SK Biopharmaceuticals Psychiatric Medications Product
Table 111. SK Biopharmaceuticals Revenue in Psychiatric Medications Business (2018-2023) & (US$ Million)
Table 112. SK Biopharmaceuticals Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychiatric Medications Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Psychiatric Medications Market Share by Type: 2024 VS 2034
Figure 3. Antidepressants Features
Figure 4. Anti-anxiety Medications Features
Figure 5. Mood-stabilizing Medications Features
Figure 6. Antipsychotic Medications Features
Figure 7. Global Psychiatric Medications Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Psychiatric Medications Market Share by Application: 2024 VS 2034
Figure 9. Hospital Use Case Studies
Figure 10. Clinic Use Case Studies
Figure 11. Household Case Studies
Figure 12. Psychiatric Medications Report Years Considered
Figure 13. Global Psychiatric Medications Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Psychiatric Medications Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Psychiatric Medications Market Share by Region: 2024 VS 2034
Figure 16. Global Psychiatric Medications Market Share by Players in 2024
Figure 17. Global Top Psychiatric Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Medications as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Psychiatric Medications Revenue in 2024
Figure 19. North America Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Psychiatric Medications Market Share by Country (2018-2034)
Figure 21. United States Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Psychiatric Medications Market Share by Country (2018-2034)
Figure 25. Germany Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Psychiatric Medications Market Share by Region (2018-2034)
Figure 33. China Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Psychiatric Medications Market Share by Country (2018-2034)
Figure 41. Mexico Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Psychiatric Medications Market Share by Country (2018-2034)
Figure 45. Turkey Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Psychiatric Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 51. Johnson & Johnson Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 53. H. Lundbeck Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 54. Abbott Laboratories Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 55. Otsuka Pharmaceutical Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 56. Gedeon Richter Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 57. Lupin Pharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 58. Luye Pharma Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 59. SK Biopharmaceuticals Revenue Growth Rate in Psychiatric Medications Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed